Latest News

A new dedicated phase I clinical trials unit at Hollings means more and different types of clinical trials will be available to cancer patients.

A new study is the first in the U.S. to show that an available generic drug could help people stop using e-cigarettes.

MUSC’s pipeline programs build the skills of underrepresented students and prepare them for careers in health care and medical research.

For people with HIV, the risk of anal cancer varies significantly depending on the region of the country where they live.

After melanoma surgery, hairdresser Carol Helton is spreading the word at her hair salon about staying on top of suspicious moles.

A clinical trial of CAR-T cell therapy developed at Hollings has received NCI funding to expand.

An Ewing sarcoma researcher at MUSC is one of three scientists nationwide to receive a career development award from the Rally Foundation.

Hollings researchers use patented technology to improve immunotherapy by prolonging survival of cancer-fighting T-cells.

Head and neck cancer surgeons at Hollings are testing a fluorescent dye that illuminates nerves, which should make them easier to find during surgery.

Through years of heartache and hard work, widower raises funds for research into the cancer that took his wife.